Publicacións en colaboración con investigadores/as de Institute Catalá Oncología (3)

2022

  1. Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study

    Cancers, Vol. 14, Núm. 23

  2. SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA

    Future Oncology, Vol. 18, Núm. 34, pp. 3791-3800

2020

  1. Fatty acid intake and breast cancer in the Spanish multicase–control study on cancer (MCC-Spain)

    European Journal of Nutrition, Vol. 59, Núm. 3, pp. 1171-1179